Geode Capital Management, LLC Benitec Biopharma Inc. Transaction History

Geode Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.18 - $0.36 $224 - $448	-1,246 Reduced 2.52%	48,223 $10,000
Q4 2022 Feb 13, 2023	SELL	$0.13 - $5.95 $1,494 - $68,413	-11,498 Reduced 18.86%	49,469 $8,000
Q3 2022 Nov 14, 2022	BUY	$0.31 - $6.32 $150 - $3,071	486 Added 0.8%	60,967 $22,000
Q2 2022 Aug 12, 2022	BUY	$0.74 - $2.29 $677 - $2,095	915 Added 1.54%	60,481 $70,000
Q1 2022 May 13, 2022	BUY	$1.96 - $2.96 $2,259 - $3,412	1,153 Added 1.97%	59,566 $139,000
Q4 2021 Feb 11, 2022	BUY	$2.62 - $3.77 $12,369 - $17,798	4,721 Added 8.79%	58,413 $153,000
Q3 2021 Nov 12, 2021	BUY	$3.49 - $4.26 $67,004 - $81,787	19,199 Added 55.66%	53,692 $191,000
Q2 2021 Aug 13, 2021	BUY	$3.94 - $5.81 $23,376 - $34,470	5,933 Added 20.77%	34,493 $146,000
Q1 2021 May 12, 2021	BUY	$2.59 - $9.26 $73,970 - $264,465	28,560 New	28,560 $147,000

1.42M

Ticker BNTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,809,500
Market Cap $280M
Description
Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.